SCHEMBL24968896

SCHEMBL24968896

C=CCc1cnc(OC)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
TP53 P04637 2/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DHFR P00374 1/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
MAPT P10636 2/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22094445 0.80 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C19CYP3A4SMN1; SMN2
SCHEMBL12476812 0.79 CD274 (0.36) ALDH1A1DHFRADRA2AADRA2BADRA2C
SCHEMBL20669649 0.78 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C19CYP3A4TSHR
SCHEMBL22094015 0.78 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C19SMN1; SMN2MAPT
SCHEMBL31309148 0.78 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C19SMN1; SMN2MAPT
SCHEMBL31309047 0.78 ALDH1A1 (0.48) ALDH1A1CYP1A2CYP2C19CYP3A4TSHR
SCHEMBL28007274 0.76 GABRA1 (0.35) ALDH1A1SMN1; SMN2CDK5MAPTADRA2A
SCHEMBL22094249 0.75 SLC6A2 (0.47) ALDH1A1CYP1A2CYP2C19KCNH2
SCHEMBL31308963 0.75 SLC6A2 (0.47) ALDH1A1CYP1A2CYP2C19KCNH2
SCHEMBL12476702 0.75 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP2C19CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240351997-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. (CN) 2024-10-24 US disclosed
EP-4378938-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) 2024-06-05 EP disclosed
WO-2023006013-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF 上海齐鲁制药研究中心有限公司 2023-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240351997-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF PARP6, PARP4, PARP3 ALDH1A1 549/4885CYP1A2 2974/4885CYP2C19 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.